{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T17:20:28Z","timestamp":1778347228379,"version":"3.51.4"},"reference-count":62,"publisher":"Oxford University Press (OUP)","issue":"D1","license":[{"start":{"date-parts":[[2017,11,13]],"date-time":"2017-11-13T00:00:00Z","timestamp":1510531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Extensive efforts have been directed at the discovery, investigation and clinical monitoring of targeted therapeutics. These efforts may be facilitated by the convenient access of the genetic, proteomic, interactive and other aspects of the therapeutic targets. Here, we describe an update of the Therapeutic target database (TTD) previously featured in NAR. This update includes: (i) 2000 drug resistance mutations in 83 targets and 104 target\/drug regulatory genes, which are resistant to 228 drugs targeting 63 diseases (49 targets of 61 drugs with patient prevalence data); (ii) differential expression profiles of 758 targets in the disease-relevant drug-targeted tissue of 12 615 patients of 70 diseases; (iii) expression profiles of 629 targets in the non-targeted tissues of 2565 healthy individuals; (iv) 1008 target combinations of 1764 drugs and the 1604 target combination of 664 multi-target drugs; (v) additional 48 successful, 398 clinical trial and 21 research targets, 473 approved, 812 clinical trial and 1120 experimental drugs, and (vi) ICD-10-CM and ICD-9-CM codes for additional 482 targets and 262 drugs against 98 disease conditions. This update makes TTD more useful for facilitating the patient focused research, discovery and clinical investigations of the targeted therapeutics. TTD is accessible at http:\/\/bidd.nus.edu.sg\/group\/ttd\/ttd.asp.<\/jats:p>","DOI":"10.1093\/nar\/gkx1076","type":"journal-article","created":{"date-parts":[[2017,11,10]],"date-time":"2017-11-10T12:10:33Z","timestamp":1510315833000},"page":"D1121-D1127","source":"Crossref","is-referenced-by-count":454,"title":["Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics"],"prefix":"10.1093","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3629-519X","authenticated-orcid":false,"given":"Ying Hong","family":"Li","sequence":"first","affiliation":[{"name":"Bioinformatics and Drug Design Group, Department of Pharmacy and Center for Computational Science and Engineering, National University of Singapore, Singapore 117543, Singapore"},{"name":"Innovative Drug Research and Bioinformatics Group, School of Pharmaceutical Sciences, Chongqing University, Chongqing 401331, China"}]},{"given":"Chun Yan","family":"Yu","sequence":"first","affiliation":[{"name":"Bioinformatics and Drug Design Group, Department of Pharmacy and Center for Computational Science and Engineering, National University of Singapore, Singapore 117543, Singapore"},{"name":"Innovative Drug Research and Bioinformatics Group, School of Pharmaceutical Sciences, Chongqing University, Chongqing 401331, China"}]},{"given":"Xiao Xu","family":"Li","sequence":"first","affiliation":[{"name":"Bioinformatics and Drug Design Group, Department of Pharmacy and Center for Computational Science and Engineering, National University of Singapore, Singapore 117543, Singapore"},{"name":"Innovative Drug Research and Bioinformatics Group, School of Pharmaceutical Sciences, Chongqing University, Chongqing 401331, China"}]},{"given":"Peng","family":"Zhang","sequence":"first","affiliation":[{"name":"Bioinformatics and Drug Design Group, Department of Pharmacy and Center for Computational Science and Engineering, National University of Singapore, Singapore 117543, Singapore"}]},{"given":"Jing","family":"Tang","sequence":"first","affiliation":[{"name":"Innovative Drug Research and Bioinformatics Group, School of Pharmaceutical Sciences, Chongqing University, Chongqing 401331, China"}]},{"given":"Qingxia","family":"Yang","sequence":"first","affiliation":[{"name":"Innovative Drug Research and Bioinformatics Group, School of Pharmaceutical Sciences, Chongqing University, Chongqing 401331, China"}]},{"given":"Tingting","family":"Fu","sequence":"first","affiliation":[{"name":"Innovative Drug Research and Bioinformatics Group, School of Pharmaceutical Sciences, Chongqing University, Chongqing 401331, China"}]},{"given":"Xiaoyu","family":"Zhang","sequence":"first","affiliation":[{"name":"Innovative Drug Research and Bioinformatics Group, School of Pharmaceutical Sciences, Chongqing University, Chongqing 401331, China"}]},{"given":"Xuejiao","family":"Cui","sequence":"first","affiliation":[{"name":"Innovative Drug Research and Bioinformatics Group, School of Pharmaceutical Sciences, Chongqing University, Chongqing 401331, China"}]},{"given":"Gao","family":"Tu","sequence":"first","affiliation":[{"name":"Innovative Drug Research and Bioinformatics Group, School of Pharmaceutical Sciences, Chongqing University, Chongqing 401331, China"}]},{"given":"Yang","family":"Zhang","sequence":"first","affiliation":[{"name":"Innovative Drug Research and Bioinformatics Group, School of Pharmaceutical Sciences, Chongqing University, Chongqing 401331, China"}]},{"given":"Shuang","family":"Li","sequence":"first","affiliation":[{"name":"Innovative Drug Research and Bioinformatics Group, School of Pharmaceutical Sciences, Chongqing University, Chongqing 401331, China"}]},{"given":"Fengyuan","family":"Yang","sequence":"first","affiliation":[{"name":"Innovative Drug Research and Bioinformatics Group, School of Pharmaceutical Sciences, Chongqing University, Chongqing 401331, China"}]},{"given":"Qiu","family":"Sun","sequence":"first","affiliation":[{"name":"Innovative Drug Research and Bioinformatics Group, School of Pharmaceutical Sciences, Chongqing University, Chongqing 401331, China"}]},{"given":"Chu","family":"Qin","sequence":"first","affiliation":[{"name":"Bioinformatics and Drug Design Group, Department of Pharmacy and Center for Computational Science and Engineering, National University of Singapore, Singapore 117543, Singapore"}]},{"given":"Xian","family":"Zeng","sequence":"first","affiliation":[{"name":"Bioinformatics and Drug Design Group, Department of Pharmacy and Center for Computational Science and Engineering, National University of Singapore, Singapore 117543, Singapore"}]},{"given":"Zhe","family":"Chen","sequence":"first","affiliation":[{"name":"Zhejiang Key Laboratory of Gastro-intestinal Pathophysiology, Zhejiang Hospital of Traditional Chinese Medicine, Zhejiang Chinese Medical University, Hangzhou 310006, China"}]},{"given":"Yu Zong","family":"Chen","sequence":"first","affiliation":[{"name":"Bioinformatics and Drug Design Group, Department of Pharmacy and Center for Computational Science and Engineering, National University of Singapore, Singapore 117543, Singapore"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8069-0053","authenticated-orcid":false,"given":"Feng","family":"Zhu","sequence":"first","affiliation":[{"name":"Bioinformatics and Drug Design Group, Department of Pharmacy and Center for Computational Science and Engineering, National University of Singapore, Singapore 117543, Singapore"},{"name":"Innovative Drug Research and Bioinformatics Group, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China"},{"name":"Innovative Drug Research and Bioinformatics Group, School of Pharmaceutical Sciences, Chongqing University, Chongqing 401331, China"}]}],"member":"286","published-online":{"date-parts":[[2017,11,13]]},"reference":[{"key":"2020041422554918400_B1","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/nrd2961","article-title":"Lessons from 60 years of pharmaceutical innovation","volume":"8","author":"Munos","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"2020041422554918400_B2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrd.2016.230","article-title":"A comprehensive map of molecular drug targets","volume":"16","author":"Santos","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"2020041422554918400_B3","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/nrd2132","article-title":"Drugs, their targets and the nature and number of drug targets","volume":"5","author":"Imming","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"2020041422554918400_B4","doi-asserted-by":"crossref","first-page":"20558","DOI":"10.1038\/srep20558","article-title":"The exploration of network motifs as potential drug targets from post-translational regulatory networks","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci. Rep."},{"key":"2020041422554918400_B5","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1080\/17460441.2016.1190706","article-title":"Using reverse docking for target identification and its applications for drug discovery","volume":"11","author":"Lee","year":"2016","journal-title":"Expert Opin. Drug Discov."},{"key":"2020041422554918400_B6","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1021\/acschemneuro.7b00173","article-title":"Differentiating physicochemical properties between addictive and nonaddictive ADHD drugs revealed by molecular dynamics simulation studies","volume":"8","author":"Wang","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"2020041422554918400_B7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1124\/pr.58.2.4","article-title":"Therapeutic targets: progress of their exploration and investigation of their characteristics","volume":"58","author":"Zheng","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"2020041422554918400_B8","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrd3478","article-title":"Trends in the exploitation of novel drug targets","volume":"10","author":"Rask-Andersen","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"2020041422554918400_B9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/cpt.318","article-title":"Leveraging big data to transform target selection and drug discovery","volume":"99","author":"Chen","year":"2016","journal-title":"Clin. Pharmacol. Ther."},{"key":"2020041422554918400_B10","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1016\/j.bbagen.2017.07.022","article-title":"Differentiating physicochemical properties between NDRIs and sNRIs clinically important for the treatment of ADHD","volume":"1861","author":"Wang","year":"2017","journal-title":"Biochim. Biophys. Acta"},{"key":"2020041422554918400_B11","doi-asserted-by":"crossref","first-page":"D1069","DOI":"10.1093\/nar\/gkv1230","article-title":"Therapeutic target database update 2016: enriched resource for bench to clinical drug target and targeted pathway information","volume":"44","author":"Yang","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"2020041422554918400_B12","doi-asserted-by":"crossref","first-page":"D1091","DOI":"10.1093\/nar\/gkt1068","article-title":"DrugBank 4.0: shedding new light on drug metabolism","volume":"42","author":"Law","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"2020041422554918400_B13","doi-asserted-by":"crossref","first-page":"D945","DOI":"10.1093\/nar\/gkw1074","article-title":"The ChEMBL database in 2017","volume":"45","author":"Gaulton","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"2020041422554918400_B14","doi-asserted-by":"crossref","first-page":"D1054","DOI":"10.1093\/nar\/gkv1037","article-title":"The IUPHAR\/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands","volume":"44","author":"Southan","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"2020041422554918400_B15","doi-asserted-by":"crossref","first-page":"D932","DOI":"10.1093\/nar\/gkw993","article-title":"DrugCentral: online drug compendium","volume":"45","author":"Ursu","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"2020041422554918400_B16","doi-asserted-by":"crossref","first-page":"D392","DOI":"10.1093\/nar\/gku1144","article-title":"PoSSuM v.2.0: data update and a new function for investigating ligand analogs and target proteins of small-molecule drugs","volume":"43","author":"Ito","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"2020041422554918400_B17","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/bioinformatics\/btv597","article-title":"PDID: database of molecular-level putative protein-drug interactions in the structural human proteome","volume":"32","author":"Wang","year":"2016","journal-title":"Bioinformatics"},{"key":"2020041422554918400_B18","doi-asserted-by":"crossref","first-page":"D959","DOI":"10.1093\/nar\/gkv1128","article-title":"ccmGDB: a database for cancer cell metabolism genes","volume":"44","author":"Kim","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"2020041422554918400_B19","doi-asserted-by":"crossref","first-page":"D932","DOI":"10.1093\/nar\/gkv1283","article-title":"CancerResource\u2013updated database of cancer-relevant proteins, mutations and interacting drugs","volume":"44","author":"Gohlke","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"2020041422554918400_B20","doi-asserted-by":"crossref","first-page":"12943","DOI":"10.1073\/pnas.1107336108","article-title":"Clustered patterns of species origins of nature-derived drugs and clues for future bioprospecting","volume":"108","author":"Zhu","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2020041422554918400_B21","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrg3922","article-title":"Evolutionary consequences of drug resistance: shared principles across diverse targets and organisms","volume":"16","author":"Hughes","year":"2015","journal-title":"Nat. Rev. Genet."},{"key":"2020041422554918400_B22","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrclinonc.2015.175","article-title":"The influence of subclonal resistance mutations on targeted cancer therapy","volume":"13","author":"Schmitt","year":"2016","journal-title":"Nat Rev. Clin Oncol."},{"key":"2020041422554918400_B23","doi-asserted-by":"crossref","first-page":"36205","DOI":"10.1038\/srep36205","article-title":"Systematic analysis of drug targets confirms expression in disease-relevant tissues","volume":"6","author":"Kumar","year":"2016","journal-title":"Sci. Rep."},{"key":"2020041422554918400_B24","doi-asserted-by":"crossref","first-page":"D787","DOI":"10.1093\/nar\/gkp1014","article-title":"Update of TTD: Therapeutic Target Database","volume":"38","author":"Zhu","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"2020041422554918400_B25","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drudis.2006.11.008","article-title":"Multi-target therapeutics: when the whole is greater than the sum of the parts","volume":"12","author":"Zimmermann","year":"2007","journal-title":"Drug Discov. Today."},{"key":"2020041422554918400_B26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.phrs.2015.09.019","article-title":"Co-targeting cancer drug escape pathways confers clinical advantage for multi-target anticancer drugs","volume":"102","author":"Tao","year":"2015","journal-title":"Pharmacol. Res."},{"key":"2020041422554918400_B27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrd2683","article-title":"Mechanisms of drug combinations: interaction and network perspectives","volume":"8","author":"Jia","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"2020041422554918400_B28","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nrd3216","article-title":"Utilizing targeted cancer therapeutic agents in combination: novel approaches and urgent requirements","volume":"9","author":"Kummar","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"2020041422554918400_B29","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S1359-6446(05)03377-5","article-title":"Computer prediction of drug resistance mutations in proteins","volume":"10","author":"Cao","year":"2005","journal-title":"Drug Discov. Today"},{"key":"2020041422554918400_B30","doi-asserted-by":"crossref","first-page":"e1000925","DOI":"10.1371\/journal.pcbi.1000925","article-title":"Drug-induced regulation of target expression","volume":"6","author":"Iskar","year":"2010","journal-title":"PLoS Comput. Biol."},{"key":"2020041422554918400_B31","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.tips.2005.02.007","article-title":"The efficiency of multi-target drugs: the network approach might help drug design","volume":"26","author":"Csermely","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"key":"2020041422554918400_B32","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1124\/jpet.108.149955","article-title":"What are next generation innovative therapeutic targets? clues from genetic, structural, physicochemical, and systems profiles of successful targets","volume":"330","author":"Zhu","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2020041422554918400_B33","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1039\/C5CP05771J","article-title":"Identification of the inhibitory mechanism of FDA approved selective serotonin reuptake inhibitors: an insight from molecular dynamics simulation study","volume":"18","author":"Xue","year":"2016","journal-title":"Phys. Chem. Chem. Phys."},{"key":"2020041422554918400_B34","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0140-6736(12)60868-X","article-title":"Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial","volume":"380","author":"Hauschild","year":"2012","journal-title":"Lancet"},{"key":"2020041422554918400_B35","doi-asserted-by":"crossref","first-page":"W162","DOI":"10.1093\/nar\/gkx449","article-title":"NOREVA: normalization and evaluation of MS-based metabolomics data","volume":"45","author":"Li","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"2020041422554918400_B36","doi-asserted-by":"crossref","first-page":"38881","DOI":"10.1038\/srep38881","article-title":"Performance evaluation and online realization of data-driven normalization methods used in LC\/MS based untargeted metabolomics analysis","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"key":"2020041422554918400_B37","doi-asserted-by":"crossref","first-page":"D777","DOI":"10.1093\/nar\/gkw1121","article-title":"COSMIC: somatic cancer genetics at high-resolution","volume":"45","author":"Forbes","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"2020041422554918400_B38","doi-asserted-by":"crossref","first-page":"D566","DOI":"10.1093\/nar\/gkw1004","article-title":"CARD 2017: expansion and model-centric curation of the comprehensive antibiotic resistance database","volume":"45","author":"Jia","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"2020041422554918400_B39","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000331998","article-title":"The HIVdb system for HIV-1 genotypic resistance interpretation","volume":"55","author":"Tang","year":"2012","journal-title":"Intervirology"},{"key":"2020041422554918400_B40","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1371\/journal.pmed.1000002","article-title":"Tuberculosis drug resistance mutation database","volume":"6","author":"Sandgren","year":"2009","journal-title":"PLoS Med."},{"key":"2020041422554918400_B41","doi-asserted-by":"crossref","first-page":"D991","DOI":"10.1093\/nar\/gks1193","article-title":"NCBI GEO: archive for functional genomics data sets\u2013update","volume":"41","author":"Barrett","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"2020041422554918400_B42","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature07385","article-title":"Comprehensive genomic characterization defines human glioblastoma genes and core pathways","volume":"455","author":"Cancer Genome Atlas Research, N.","year":"2008","journal-title":"Nature"},{"key":"2020041422554918400_B43","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/bioinformatics\/btp697","article-title":"DCDB: drug combination database","volume":"26","author":"Liu","year":"2010","journal-title":"Bioinformatics"},{"key":"2020041422554918400_B44","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nrg2778","article-title":"The population genetics of antibiotic resistance: integrating molecular mechanisms and treatment contexts","volume":"11","author":"MacLean","year":"2010","journal-title":"Nat. Rev. Genet."},{"key":"2020041422554918400_B45","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/ng1671","article-title":"Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR","volume":"37","author":"Bell","year":"2005","journal-title":"Nat. Genet."},{"key":"2020041422554918400_B46","doi-asserted-by":"crossref","first-page":"D204","DOI":"10.1093\/nar\/gku989","article-title":"UniProt: a hub for protein information","volume":"43","author":"UniProt","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"2020041422554918400_B47","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nbt0410-322","article-title":"A global map of human gene expression","volume":"28","author":"Lukk","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"2020041422554918400_B48","doi-asserted-by":"crossref","first-page":"e0157484","DOI":"10.1371\/journal.pone.0157484","article-title":"Identification of cancer related genes using a comprehensive map of human gene expression","volume":"11","author":"Torrente","year":"2016","journal-title":"PLoS One"},{"key":"2020041422554918400_B49","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","article-title":"affy\u2013analysis of Affymetrix GeneChip data at the probe level","volume":"20","author":"Gautier","year":"2004","journal-title":"Bioinformatics"},{"key":"2020041422554918400_B50","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/bioinformatics\/19.2.185","article-title":"A comparison of normalization methods for high density oligonucleotide array data based on variance and bias","volume":"19","author":"Bolstad","year":"2003","journal-title":"Bioinformatics"},{"key":"2020041422554918400_B51","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1525-1578(10)60455-2","article-title":"Analysis of microarray data using Z score transformation","volume":"5","author":"Cheadle","year":"2003","journal-title":"J. Mol. Diagn."},{"key":"2020041422554918400_B52","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nrd2089","article-title":"Strategies for optimizing combinations of molecularly targeted anticancer agents","volume":"5","author":"Dancey","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"2020041422554918400_B53","doi-asserted-by":"crossref","first-page":"D12","DOI":"10.1093\/nar\/gkw1071","article-title":"Database Resources of the National Center for Biotechnology Information","volume":"45","author":"Coordinators","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"2020041422554918400_B54","doi-asserted-by":"crossref","first-page":"D376","DOI":"10.1093\/nar\/gku947","article-title":"CATH: comprehensive structural and functional annotations for genome sequences","volume":"43","author":"Sillitoe","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"2020041422554918400_B55","doi-asserted-by":"crossref","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","article-title":"KEGG as a reference resource for gene and protein annotation","volume":"44","author":"Kanehisa","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"2020041422554918400_B56","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0022-2836(05)80360-2","article-title":"Basic local alignment search tool","volume":"215","author":"Altschul","year":"1990","journal-title":"J. Mol. Biol."},{"key":"2020041422554918400_B57","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1758-2946-5-24","article-title":"JSME: a free molecule editor in JavaScript","volume":"5","author":"Bienfait","year":"2013","journal-title":"J. Cheminform."},{"key":"2020041422554918400_B58","doi-asserted-by":"crossref","first-page":"D1118","DOI":"10.1093\/nar\/gkt1129","article-title":"Therapeutic target database update 2014: a resource for targeted therapeutics","volume":"42","author":"Qin","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"2020041422554918400_B59","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/nar\/30.1.412","article-title":"TTD: therapeutic target database","volume":"30","author":"Chen","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"2020041422554918400_B60","doi-asserted-by":"crossref","first-page":"D1128","DOI":"10.1093\/nar\/gkr797","article-title":"Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery","volume":"40","author":"Zhu","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"2020041422554918400_B61","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrc3930","article-title":"Building better monoclonal antibody-based therapeutics","volume":"15","author":"Weiner","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"2020041422554918400_B62","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd.2016.246","article-title":"MicroRNA therapeutics: towards a new era for the management of cancer and other diseases","volume":"16","author":"Rupaimoole","year":"2017","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["Nucleic Acids Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/nar\/article-pdf\/46\/D1\/D1121\/33043781\/gkx1076.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/nar\/article-pdf\/46\/D1\/D1121\/33043781\/gkx1076.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T02:56:27Z","timestamp":1586919387000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/nar\/article\/46\/D1\/D1121\/4621327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,13]]},"references-count":62,"journal-issue":{"issue":"D1","published-online":{"date-parts":[[2017,11,13]]},"published-print":{"date-parts":[[2018,1,4]]}},"URL":"https:\/\/doi.org\/10.1093\/nar\/gkx1076","relation":{},"ISSN":["0305-1048","1362-4962"],"issn-type":[{"value":"0305-1048","type":"print"},{"value":"1362-4962","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,1,4]]},"published":{"date-parts":[[2017,11,13]]}}}